Quantcast
Showing posts with label Search. Show all posts
Showing posts with label Search. Show all posts

Thursday, September 2, 2010

Free online database of ADME, PK, and physicochemical data

Free online database of marketed drugs
ADME, PK, and physicochemical data
Aid your drug discovery and development

Features

Search the database for phys-chem, ADME and PK
properties of marketed drugs

Free online access via www.cloegateway.com
2D and 3D visualisation tools for viewing the relationships between ADME and physicochemical properties
All drugs are classified using the WHO ATC classification index, allowing identification of drugs by therapeutic area
Data compiled from Cyprotex in vitro ADME testing and literature values

SciVerse

Effective August 28, 2010 ScienceDirect, Scopus and the targeted web content from Scirus have been integrated within one platform - SciVerse.
(NB All existing URLs will remain active and there will be no interruption of inward or outward links to your subscribed content.)
Go to www.sciverse.com to access the SciVerse platform.
The home page for SciVerse is the new SciVerse Hub beta from which users can access:
Search results across ScienceDirect, Scopus and scientific web content, ranked by relevance and without duplication
Three free applications that enhance search and discovery, allowing you to:
Search only the methods/experimental procedures sections of the articles in ScienceDirect
See search results in full sentences to help find the right content faster
See a list of the most prolific authors for a given search topic
For more information (including answers to frequently asked questions) about SciVerse and the new releases of ScienceDirect and Scopus, please visit www.info.sciverse.com

Saturday, March 7, 2009

Search engine with Google/Yahoo/MSN results and user comments all on one page

Scour is the next gen search engine with Google/Yahoo/MSN results and user comments all on one page. Best of all we get paid for using it by earning points with every search, comment and vote. The points are redeemable for Visa gift cards! It's like earning credit card or airline points just for searching! Hit the link below to join for free and we will both get points!

http://scour.com/invite/tsalman/


I know you'll like it!

Thursday, February 26, 2009

Online access results in more citations?


Science 20 February 2009:Vol. 323. no. 5917, p. 1025DOI: 10.1126/science.1154562

Brevia
Open Access and Global Participation in Science
James A. Evans and Jacob Reimer
Previous investigations into the impact of open-access journals on subsequent citations confounded open and electronic access and failed to track availability over time. With new data, we separated these effects. We demonstrate that a journal receives a modest increase in citations when it comes online freely, but the jump is larger when it first comes online through commercial sources. This effect reverses for poor countries where free-access articles are much more likely to be cited. Together, findings suggest that free Internet access widens the circle of those who read and make use of scientists' investigations.
Free online availability of scientific articles increases the likelihood of papers getting cited, especially in the developing world and in the biomedical sciences, according to this new study published in Science.
The question of whether open access drives citations has been hotly contested among scientists, policymakers, and editors, with several recent studies coming down on different sides of the debate. In the most extensive study to date -- covering around 26 million articles from more than 8,000 journals published from 1998 to 2005 -- University of Chicago sociologist James Evans, together with neurobiology grad student Jacob Reimer, found that making an article freely available on the internet increased the number of citations, but only by about 8%, which was far less than some previous claims. When the authors looked just at poorer countries, however, they found that the influence of open access was more than twice as strong. For example, in Bulgaria and Chile, researchers cited nearly 20% more open access articles, and in Turkey and Brazil, the number of citations rose by more than 25%. Free online availability "is not a huge driver of science in the first world, but it shapes parts of science in the rest of world," Evans told The Scientist. "Scientists and scholars in poorer countries are disproportionately citing articles that are freely available to them." "The results make a lot of sense," Gunther Eysenbach, a health policy and e-health researcher at the University of Toronto who was not involved in the research, told The Scientist. "In countries with lower income, the [open access] effect is bigger than in countries where researchers have access to the literature anyway -- that's quite intuitive." Stevan Harnad, an open access advocate and cognitive neuroscientist at the University of Quebec at Montreal who was not involved with the study, said that the authors should have compared public and private institutions closer to home to test whether the same effect was true in the developed world. "[Evans] looked at the big picture, but he could have cut the cake a bit finer and found the same effects if he compared the Harvards and the have nots," Harnad told The Scientist. "It's a shame that with such rich data he didn't look at other such important and pressing questions." Free online access conferred the greatest citation advantage in the life sciences, and no significant influence in three areas -- chemistry, physics and the social sciences -- which the authors chalked up to a culture of pre-print databases and personal archiving. Although open access had a modest overall influence, commercial online availability had an even greater effect. This indicates that most researchers are turning to the internet to find papers, though they may rely largely on institutional subscriptions, said Evans. "The larger influence is of things being online," whether commercially or not. Philip Davis, a Cornell University grad student in science communications who also studies the effects of open access on citation records, praised the article's size and breadth, but noted that Evans "can't measure the article-level details, he can only look at the journal level." The study lumped together articles from entire journal volumes, which overlooks author-pay models that make some but not all articles in a journal freely available, Davis noted.

Thursday, January 22, 2009

New impact metric by PLoS ONE

In an attempt to provide alternative metrics to the traditional journal impact factor, the open-access journal Public Library of Science ONE announced that it will release a slew of alternative impact data about individual articles in the coming months. The new "articles-level metrics project" -- which will post usage data, page views, citations from Scopus and CrossRef, social networlking links, press coverage, comments, and user ratings for each of PLoS ONE's thousands of articles -- was announced by Peter Binfield, the journal's managing editor.
"No one has any data other than [ISI] impact factors," Binfield told The Scientist. "Our idea is to throw up a bunch of metrics and see what people use." From its inception at the end of 2006, PLoS ONE has eschewed the notion of impact factors. (It is not currently listed by the ISI Web of Science's rankings.) Binfield argued that the traditional impact factor judges a journal's overall performance, rather than assessing impact at the article-level. The new scheme, however, is aimed at evaluating each article on its own merits, regardless of the other papers in the same journal, he said. Binfield hopes that the journal's readers will use the information to come to their conclusions. "We're putting the data out there and letting the world figure it out." Eventually, Binfield hopes that readers will be able to personalize how they view the data, and sort articles according to the metric of their choice. "The more metrics we have, the more it'll lead to a dilution of any one [metric]," said Bjoern Brembs, a neuroscientist at the Free University of Berlin in Germany and member of PLoS ONE's editorial board.

How PharmaLive (Exclusive Pharma search engine) works

To search, click here
Results are focused specifically on authoritative sources for the pharmaceutical professional. PharmaLiveSearch is aimed specifically at professionals in the pharmaceutical industry and provides several important refinements of the search process that are particularly relevant to pharmaceutical related searches.
Precision-Tuned SearchSearch Scopes
PharmaLiveSearch has three different search scopes from which to choose:
“Publisher Recommended Sites” designates a set of more than 25,000,000 documents from more than 2,600 domains and focuses on the most relevant pharmaceutical sites as chosen by the editors. As a result, spam and irrelevant documents have already been filtered.
“Search PharmaLive” provides the option to search results within the PharmaLive Website. “Search Web” provides results beyond selected domains, but they are ranked for relevance and filtered for spam.
Search Categories
Within each scope you can search by categories, represented by tabs at the top of the search results. PharmaLiveSearch sorts results into different categories based on the type of information source.
Categories within the Publisher Recommended Sites include:
Companies (results from the top pharmaceutical companies in the industry)
Government (results from top drug sites)
Research and Development (results from drug research organizations)
Media (results from top journals and pharmaceutical publications)
Associations (results from various health and medical related organizations)
Main results
The main results for your query are listed in the largest central window of the results page, ranked by relevance to the query and date published. A “P” symbol reflects that the information in the document is password protected and/or requires a subscription. You may need to register with the organization responsible for the Website to get full access to that document. A PDF symbol next to a result shows that page is available in Portable Document Format only.
PharmaLiveSearch filters duplicate records, therefore results initially reported will almost always be greater than the actual number available. To view all results including duplicates, go to the last search results page and click on the link at the bottom of the results.
PharmaLiveSearch is also unique in that it implements knowledge associated with the pharmaceutical industry. It recognizes many industry-specific acronyms (e.g., “FDA”, “ALS”) and industry synonyms (e.g., “high blood pressure” and “hypertension”). It also recognizes more general and specific concepts for many drugs and diseases (e.g., brand names or generic versions of many drugs). This knowledge is used to increase the accuracy of searches, improve displayed results, and retrieve more relevant results.

pharmaceutical-industry specific search engine

PharmaLiveSearch.com generates more precise results than general search engines, eliminating irrelevant links. PharmaLiveSearch.com suggests broader and narrower search terms, recommends related search terms, and displays the most popular searches.
Enter a keyword in the search box to query information on companies, products, diseases, therapeutic categories, and more:
http://www.pharmalivesearch.com/search?qgeneral=&searchtype=defLink

Exclusive Academic Pharma Research Website

"www.pharmaresearch.in" is the India's 1st exclusive and free Pharma website for academic research to bridge the existing lacuna between academic institutes and Pharma industry association and to provide the research problems to all research scholars by industrial experts for the research deliberations and rational solutions. The research theme will be actual research problems/research in the areas of R&D, F&D, Pharmacology, Biotechnology and Herbal drug Technology units and thus it will offer a paramount opportunity to each of the research scholars to show their potentials according to need of research in Pharma industry.
Apart from this, website will also provide as a sole destination to many information On
latest Pharma news about seminars & workshops in India, Free access to Pharma journals, Indian Pharma publications, Impact factor for Pharma journals, Pharmaweb links, Free Pharma Software, Sources of financial assistance for research project in India, sources for travel grants, List of CROs in India, List of facilities for instrumental analysis, List of facilities for herbarium and plant identification and many more Pharma updates.

Sunday, March 16, 2008

Tool to find relevant journals

Have you recently written a paper, but you're not sure to which journal you should submit it? Or are you an editor, and do you need to find reviewers for a particular paper? Jane can help!

Just enter the title and/or abstract of the paper in the box, and click on 'Find journals' or 'Find authors'. Jane will then compare your document to millions of documents in Medline to find the best matching journals or authors.

New!

Jane now also includes information on whether journals are open access or deposit in PubMed Central. See "Show extra options" for new search options.
Click here.
This tool is similar to eTBLAST. http://invention.swmed.edu/etblast/etblast.shtml .
Please compare the two and give your comments.

Friday, February 16, 2007

Biobar

The biobar is a bioinformatics power-browsingtoolbar for Mozilla-based browsers including Firefoxand Netscape 7+. This toolbar provides access to allmajor biological data resources. The primary advantageof this tool is that it allows the user to browseand retrieve data from Genomic, Proteomic, Functional,Literature, Taxonomic, Structural, Plant andAnimal-specific databases. In addition to the browsingfeatures, biobar also provides links to importantbioinformatics sites and services including servicesat the European Bioinformatics Institute (EBI),National Center for Biotechnology Information (NCBI) as well asmedline. The latest release provides browsing access to over 42different databases (including Google Scholar, HubMed etc).Visit: http://biobar.mozdev.org/index.html for more.

Free Books, powerpoint presentations, teaching tools and resources and drug information